Belite Bio Inc ADR (BLTE) — Cash Flow-to-Debt Ratio
Belite Bio Inc ADR (BLTE) has a Cash Flow-to-Debt Ratio of -1.03x as of December 2025, meaning its operating cash flow of $-10.38 Million could theoretically repay -1% of its total liabilities ($10.07 Million) in one year. See BLTE free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Belite Bio Inc ADR Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Belite Bio Inc ADR across 6 annual periods. Also explore net asset growth rate of Belite Bio Inc ADR to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Belite Bio Inc ADR (2020–2025)
Year-by-year debt coverage analysis for Belite Bio Inc ADR. For market capitalisation and broader financial context, see Belite Bio Inc ADR stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.67x | $-36.99 Million | $10.07 Million | ▲ +20.7% |
| 2024 | -4.63x | $-29.23 Million | $6.31 Million | ▲ +34.6% |
| 2023 | -7.09x | $-29.84 Million | $4.21 Million | ▼ -71.4% |
| 2022 | -4.13x | $-11.46 Million | $2.77 Million | ▼ -1749.4% |
| 2021 | -0.22x | $-7.47 Million | $33.44 Million | ▼ -64.9% |
| 2020 | -0.14x | $-4.44 Million | $32.78 Million | — |